Key statistics
On Thursday, Alkermes Plc (ALKS:NSQ) closed at 27.70, -15.75% below its 52-week high of 32.88, set on Feb 16, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 28.13 |
---|---|
High | 28.18 |
Low | 27.49 |
Bid | 26.00 |
Offer | 29.11 |
Previous close | 27.91 |
Average volume | 1.64m |
---|---|
Shares outstanding | 161.80m |
Free float | 159.67m |
P/E (TTM) | 9.39 |
Market cap | 4.48bn USD |
EPS (TTM) | 2.95 USD |
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
- Alkermes to Participate in Two Upcoming Investor Conferences
- Alkermes Highlights Presentations From Across Neuroscience Portfolio at Key Fall 2024 Scientific Conferences
- Alkermes plc Reports Third Quarter 2024 Financial Results
- Alkermes to Report Third Quarter Financial Results on October 24, 2024
- Alkermes to Host Investor Event to Review Orexin Portfolio Strategy
- Alkermes to Present Positive Clinical Data From Phase 1b Study of ALKS 2680 in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia at Sleep Europe 2024
- Alkermes to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Conference
- Alkermes Announces Launch of 7th Annual Alkermes Pathways Research Awards® Program
- Alkermes to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
More ▼